Home ⟩ Insights

Insights

interviews

irwin simon ceo tilray brands cannabis canada brewdog marijuana medical

5 min read • May 8, 2026

Tilray CEO Says Schedule III Marks A Turning Point For U.S. Medical Cannabis

4 min read • May 7, 2026

Exclusive: Alcohol Industry Tells Congress Its Model Can Support Hemp Regulation

4 min read • May 6, 2026

Exclusive: California Rolls Out New Guidance to Help Cannabis Businesses Prepare for Federal Rescheduling

4 min read • May 5, 2026

“This Isn’t Isolated”: NY Cannabis Enforcement Case Highlights Hemp Market Supply Chain Risks

cannabis investors rescheduling marijuana

4 min read • May 5, 2026

DEA Registration Window Opens: What Cannabis Operators and Investors Must Do Next

4 min read • May 5, 2026

Exclusive: Nabis Fast-Tracks New Jersey Entry Through Strategic Cannabis Distribution Deal

5 min read • May 2, 2026

Industry Attorneys Weigh In as Federal Cannabis Rescheduling Heads to June 29 Hearing

3 min read • May 1, 2026

The U.S. Cannabis Export Window Is Open — But Only for Those Who Can Clear the Bar

3 min read • April 30, 2026

Medical Cannabis Operators Face New Federal Compliance Costs as Schedule III Shift Advances

stock stocks markets chart psychedelics cannabis

4 min read • April 28, 2026

Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck

4 min read • April 27, 2026

Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect

4 min read • April 27, 2026

EXCLUSIVE: Safe Harbor Launches First Cannabis‑Ready 401K Plan

Latest Headlines

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.